AL2846

· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for AL2846, covering 2020-07-21 to 2025-12-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AL2846 Capsule Versus Placebo in the Treatment of Advanced Radioiodine-Refractory Differentiated Thyroid Carcinoma [Phase 3]

See pricing